#BEGIN_DRUGCARD DB02005

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C5H6O3

# Chemical_IUPAC_Name:
(3E)-2-oxopent-3-enoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Oxo-3-Pentenoic Acid

# HET_ID:
OXP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C5H6O3/c1-2-3-4(6)5(7)8/h2-3H,1H3,(H,7,8)/b3-2+

# InChI_Key:
InChIKey=IWARWSDDJHGZOW-NSCUHMNNSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2005

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
114.0993

# Molecular_Weight_Mono:
114.031694058

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1BJP

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.77

# Predicted_LogS:
-0.76

# Predicted_Water_Solubility:
1.98e+01 g/l

# Primary_Accession_No:
DB02005

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
5780665

# PubChem_Substance_ID:
46504701

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02462

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C\C=C\C(=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:42 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M95650

# Drug_Target_1_GenBank_ID_Protein:
151717

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
xylH

# Drug_Target_1_Gene_Sequence:
>192 bp
ATGCCTATTGCCCAGATCCACATCCTTGAAGGCCGCAGCGACGAGCAGAAGGAAACCCTG
ATTCGGGAAGTCAGTGAGGCCATCTCGCGCTCCCTGGATGCGCCGCTGACCAGCGTGCGA
GTGATTATCACGGAGATGGCCAAGGGCCACTTCGGCATCGGCGGCGAACTGGCCAGCAAG
GTCAGACGCTGA

# Drug_Target_1_General_Function:
Involved in isomerase activity

# Drug_Target_1_General_References:
12534468	Greated A, Lambertsen L, Williams PA, Thomas CM: Complete sequence of the IncP-9 TOL plasmid pWW0 from Pseudomonas putida. Environ Microbiol. 2002 Dec;4(12):856-71.
1339435	Chen LH, Kenyon GL, Curtin F, Harayama S, Bembenek ME, Hajipour G, Whitman CP: 4-Oxalocrotonate tautomerase, an enzyme composed of 62 amino acid residues per monomer. J Biol Chem. 1992 Sep 5;267(25):17716-21.
8510667	Harayama S, Rekik M: Comparison of the nucleotide sequences of the meta-cleavage pathway genes of TOL plasmid pWW0 from Pseudomonas putida with other meta-cleavage genes suggests that both single and multiple nucleotide substitutions contribute to enzyme evolution. Mol Gen Genet. 1993 May;239(1-2):81-9.
8547259	Subramanya HS, Roper DI, Dauter Z, Dodson EJ, Davies GJ, Wilson KS, Wigley DB: Enzymatic ketonization of 2-hydroxymuconate: specificity and mechanism investigated by the crystal structures of two isomerases. Biochemistry. 1996 Jan 23;35(3):792-802.
8547260	Stivers JT, Abeygunawardana C, Mildvan AS, Hajipour G, Whitman CP, Chen LH: Catalytic role of the amino-terminal proline in 4-oxalocrotonate tautomerase: affinity labeling and heteronuclear NMR studies. Biochemistry. 1996 Jan 23;35(3):803-13.
9778344	Taylor AB, Czerwinski RM, Johnson WH Jr, Whitman CP, Hackert ML: Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis. Biochemistry. 1998 Oct 20;37(42):14692-700.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2569

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
6942

# Drug_Target_1_Name:
4-oxalocrotonate tautomerase

# Drug_Target_1_Number_of_Residues:
63

# Drug_Target_1_PDB_ID:
4OTC

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01361	Tautomerase

# Drug_Target_1_Protein_Sequence:
>4-oxalocrotonate tautomerase
MPIAQIHILEGRSDEQKETLIREVSEAISRSLDAPLTSVRVIITEMAKGHFGIGGELASK
VRR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the ketonization of 2-hydroxymuconate stereoselectively to yield 2-oxo-3-hexenedioate

# Drug_Target_1_SwissProt_ID:
Q01468

# Drug_Target_1_SwissProt_Name:
4OT1_PSEPU

# Drug_Target_1_Synonyms:
4-OT
EC 5.3.2.-

# Drug_Target_1_Theoretical_pI:
7.72

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02005
